| Total CAM use | CAM provider | Natural remedies | Self-help practices | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
% (n = 153) | % (n = 207) | p-value | % (n = 80) | % (n = 207) | p-value | % (n = 47) | % (n = 313) | p-value | % (n = 95) | % (n = 265) | p-value | |
Cancer site1 | Yes | No | Â | Yes | No | Â | Yes | No | Â | Yes | No | Â |
 Breast | 58.2 (85) | 41.8 (61) | < 0.001* | 35.6 (52) | 64.4 (94) | < 0.001* | 13.7 (20) | 86.3 (126) | 0.765* | 39.0 (57) | 61.0 (89) | < 0.001* |
 Gastro intestinal | 25.0 (12) | 75.5 (36) | 0.008* | 8.3 (4) | 91.7 (44) | 0.013* | 14.6 (7) | 85.4 (41) | 0.736* | 18.8 (9) | 81.3 (39) | 0.197* |
 Male genitalia | 25.0 (9) | 75.0 (27) | 0.025* | 8.3 (3) | 91.7 (33) | 0.035* | 8.3 (3) | 91.7 (33) | 0.600^ | 11.1 (4) | 88.9 (32) | 0.028* |
 Female genitalia | 58.8 (20) | 41.2 (14) | 0.043* | 29.4 (10) | 70.6 (24) | 0.289* | 20.6 (7) | 79.4 (27) | 0.181^ | 44.1 (15) | 55,9 (19) | 0.014* |
 Lymphoma | 27.3 (9) | 72.7 (24) | 0.063* | 12.1 (4) | 87.9 (29) | 0.143* | 6.1 (2) | 93.9 (31) | 0.284^ | 15.2 (5) | 84,8 (28) | 0.124* |
 Head and neck | 52.9 (9) | 47.1 (8) | 0.372* | 17.6 (3) | 82.4 (14) | 0.773^ | 17.6 (3) | 82.4 (14) | 0.474^ | 29.4 (5) | 70,6 (12) | 0.780^ |
 Malignant melanoma | 28.6 (4) | 71.4 (10) | 0.282* | 21.4 (3) | 78.6 (11) | 1.000^ | 0.0 (0) | 100 (14) | 0.231^ | 14.3 (2) | 85,7 (12) | 0.371^ |
 Lung | 36.4 (4) | 63.6 (7) | 0.765^ | 18.2 (2) | 81.8 (9) | 1.000^ | 27.3 (3) | 72.7 (8) | 0.162^ | 9.1 (1) | 90,9 (10) | 0.300^ |
 Sarcoma | 63.6 (7) | 36.4 (4) | 0.215^ | 36.4 (4) | 63.6 (7) | 0.271^ | 27.3 (3) | 72.7 (8) | 0.162^ | 36.4 (4) | 63,6 (7) | 0.490^ |
 Leukemia | 0.0 (0) | 100 (9) | 0.012^ | 0.0 (0) | 100 (9) | 0.216^ | 0.0 (0) | 100 (9) | 0.612^ | 0.0 (0) | 100 (9) | 0.119^ |
 Bone marrow | 25.0 (2) | 75.0 (6) | 0.475^ | 25.0 (2) | 75.0 (6) | 1.000^ | 12.5 (1) | 87.5 (7) | 1.000^ | 0.0 (0) | 100 (8) | 0.116^ |
 Other cancer sites | 32.6 (14) | 67.4 (29) | 0.160* | 11.6 (4) | 88.4 (38) | 0.075* | 14.0 (6) | 86.0 (37) | 0.852* | 20.9 (9) | 79.1 (34) | 0.387* |
In active cancer treatment | Â | Â | 0.427* | Â | Â | 0.425* | Â | Â | 0.144* | Â | Â | 0.039* |
 Yes | 39.7 (50) | 60.3 (7) |  | 24.6 (31) | 75.4 (95) |  | 9.5 (12) | 90.5 (114) |  | 19.8 (25) | 80.2 (101) |  |
 No | 44.0 (103) | 56.0 (131) |  | 20.9 (49) | 79.1 (185) |  | 15.0 (35) | 85.0 (199) |  | 29.9 (70) | 70.1 (164) |  |
Late and long-term effects | ||||||||||||
 Fatigue | 47.5 (122) | 52.5 (135) | 0.003* | 24.1 (62) | 75.9 (195) | 0.170* | 13.6 (35) | 86.4 (222) | 0.616* | 31.1 (80) | 68.9 (177) | 0.001* |
 Sleep disorder | 53.3 (96) | 46.7 (84) | < 0.001* | 28.9 (52) | 71.1 (128) | 0.002* | 15.6 (28) | 84.4 (152) | 0.159* | 32.8 (59) | 67.2 (121) | 0.006* |
 Hot flashes | 55.3 (94) | 44.7 (76) | < 0.001* | 30.0 (51) | 70.0 (119) | < 0.001* | 17.1 (29) | 82.9 (141) | 0.033* | 35.9 (61) | 64.1 (109) | < 0.001* |
 Nerve damage (polyneuropathy) | 52.7 (87) | 47.3 (78) | < 0.001* | 26.7 (44) | 73.3 (121) | 0.062* | 14.5 (24) | 85.8 (141) | 0.440* | 35.8 (59) | 64.2 (106) | < 0.001* |
 Pain | 54.1 (86) | 45.9 (73) | < 0.001* | 30.2 (48) | 69.8 (111) | 0.001* | 15.1 (24) | 84.9 (135) | 0.307* | 35.8 (57) | 64.2 (102) | < 0.001* |
 Decreased muscle strength and mobility | 52.5 (83) | 47.5 (75) | < 0.001* | 30.4 (48) | 69.6 (110) | < 0.001* | 15.8 (25) | 84.2 (133) | 0.168* | 32.9 (52) | 67.1 (106) | 0.013* |
 Cognitive challenges | 63.1 (94) | 36.9 (55) | < 0.001* | 34.2 (51) | 65.8 (98) | < 0.001* | 17.4 (26) | 82.6 (123) | 0.038* | 14.6 (62) | 58.4 (87) | < 0.001* |
 Sexual problems | 46.7 (64) | 53.5 (73) | 0.205* | 24.1 (33) | 75.9 (104) | 0.505* | 15.3 (21) | 84.7 (116) | 0.316* | 29.2 (40) | 70.8 (97) | 0.343* |
 Gained weight | 53.4 (63) | 46.6 (55) | 0.004* | 32.2 (38) | 67.8 (80) | 0.001* | 16.9 (20) | 83.1 (98) | 0.126* | 30.5 (36) | 69.5 (82) | 0.216* |
 Anxiety or depression | 55.2 (53) | 44.8 (43) | 0.003* | 30.2 (29) | 69.8 (67) | 0.028* | 15.6 (15) | 84.4 (81) | 0.383* | 36.5 (35) | 63.5 (61) | 0.009* |
 Early menopause | 66.7 (60) | 33.3 (30) | < 0.001* | 41.1 (37) | 58.9 (53) | < 0.001* | 16.7 (15) | 83.3 (75) | 0.240* | 48.9 (44) | 51.1 (46) | < 0.001* |
 Mouth/tooth-problems and reduced taste | 56.0 (47) | 44.0 (37) | 0.004* | 31.0 (26) | 69.0 (58) | 0.028* | 14.3 (12) | 85.7 (72) | 0.702* | 28.6 (24) | 71.4 (60) | 0.604* |
 Urinary tract problems | 42.3 (33) | 57.7 (45) | 0.969* | 20.5 (16) | 79.5 (62) | 0.682* | 14.1 (11) | 85.9 (67) | 0.756* | 26.9 (21) | 73.1 (57) | 0.904* |
 Diarrhea | 52.6 (41) | 47.4 (37) | 0.042* | 26.9 (21) | 73.1 (57) | 0.259* | 16.7 (13) | 83.3 (65) | 0.285* | 33.3 (26) | 66.7 (52) | 0.116* |
 Constipation | 52.8 (38) | 47.2 (34) | 0.049* | 31.9 (23) | 68.1 (49) | 0.027* | 18.1 (13) | 81.9 (59) | 0.159* | 33.3 (24) | 66.7 (48) | 0.135* |
 Lymphedema | 55.4 (36) | 44.6 (29) | 0.020* | 32.3 (21) | 67.7 (44) | 0.031* | 15.4 (10) | 84.6 (55) | 0.538* | 29.2 (19) | 70.8 (46) | 0.566* |
 Heart- and lung problems | 46.2(18) | 53.8 (21) | 0.625* | 25.6 (10) | 74.4 (29) | 0.587* | 20.5 (8) | 79.5 (31) | 0.143* | 28.2 (11) | 71.8 (28) | 0.785* |
 Reduced fertility | 57.6 (19) | 42.4 (14) | 0.066* | 27.3 (9) | 72.7 (24) | 0.464* | 9.1 (3) | 90.9 (30) | 0.597^ | 36.4 (12) | 63.6 (21) | 0.173* |
 Weight loss | 40.0 (12) | 60.0 (18) | 0.772* | 16.7 (5) | 83.3 (25) | 0.445* | 6.7 (2) | 93.3 (28) | 0.399^ | 23.3 (7) | 76.7 (23) | 0.692* |
Other late and long-term effects | 35.4 (23) | 64.6 (42) | 0.200* | 15.4 (10) | 84.6 (55) | 0.143* | 16.9 (11) | 83.1 (54) | 0.307* | 21.5 (14) | 78.5 (51) | 0.327* |